首页    期刊浏览 2024年12月06日 星期五
登录注册

文章基本信息

  • 标题:Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
  • 本地全文:下载
  • 作者:Kasper W. ter Horst ; Mireille J. Serlie
  • 期刊名称:Nutrients
  • 电子版ISSN:2072-6643
  • 出版年度:2017
  • 卷号:9
  • 期号:9
  • 页码:981
  • DOI:10.3390/nu9090981
  • 语种:English
  • 出版社:MDPI Publishing
  • 摘要:Increased fructose consumption has been suggested to contribute to non-alcoholic fatty liver disease (NAFLD), dyslipidemia, and insulin resistance, but a causal role of fructose in these metabolic diseases remains debated. Mechanistically, hepatic fructose metabolism yields precursors that can be used for gluconeogenesis and de novo lipogenesis (DNL). Fructose-derived precursors also act as nutritional regulators of the transcription factors, including ChREBP and SREBP1c, that regulate the expression of hepatic gluconeogenesis and DNL genes. In support of these mechanisms, fructose intake increases hepatic gluconeogenesis and DNL and raises plasma glucose and triglyceride levels in humans. However, epidemiological and fructose-intervention studies have had inconclusive results with respect to liver fat, and there is currently no good human evidence that fructose, when consumed in isocaloric amounts, causes more liver fat accumulation than other energy-dense nutrients. In this review, we aim to provide an overview of the seemingly contradicting literature on fructose and NAFLD. We outline fructose physiology, the mechanisms that link fructose to NAFLD, and the available evidence from human studies. From this framework, we conclude that the cellular mechanisms underlying hepatic fructose metabolism will likely reveal novel targets for the treatment of NAFLD, dyslipidemia, and hepatic insulin resistance. Finally, fructose-containing sugars are a major source of excess calories, suggesting that a reduction of their intake has potential for the prevention of NAFLD and other obesity-related diseases.
  • 关键词:fructose; hepatic steatosis; NAFLD; de novo lipogenesis; lipid synthesis; ChREBP; insulin resistance; obesity; metabolic syndrome fructose ; hepatic steatosis ; NAFLD ; de novo lipogenesis ; lipid synthesis ; ChREBP ; insulin resistance ; obesity ; metabolic syndrome
国家哲学社会科学文献中心版权所有